ReShape Lifesciences
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,805 | $2,292 | $1,965 | $1,944 |
Gross Profit | 1,319 | 1,439 | 1,134 | 1,165 |
EBITDA | -1,774 | -1,756 | -2,048 | -2,204 |
EBIT | -1,757 | -1,761 | -2,054 | -2,210 |
Net Income | -1,761 | -1,581 | -1,595 | -2,193 |
Net Change In Cash | 1,805 | 2,292 | 1,965 | 1,944 |
Free Cash Flow | -687 | -311 | -1,357 | -2,072 |
Cash | 693 | 743 | 1,053 | 2,479 |
Basic Shares | 515 | 508 | 434 | 404 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $8,006 | $8,678 | $11,240 | $13,600 |
Gross Profit | 5,057 | 5,548 | 6,802 | 8,348 |
EBITDA | -6,668 | -14,485 | -24,925 | -25,778 |
EBIT | -14,639 | -27,078 | -27,749 | |
Net Income | -7,130 | -11,387 | -46,214 | -61,933 |
Net Change In Cash | 8,006 | 8,678 | 11,240 | 13,600 |
Free Cash Flow | -4,427 | -17,003 | -22,033 | -15,727 |
Cash | 693 | 4,459 | 3,855 | 22,765 |
Basic Shares | 515 | 102 | 7 | 3 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$3.10 |
2024-06-30 | -$0.06 |
2024-03-31 | -$0.09 |
2023-12-31 | -$0.11 |
